| 000 | 03039cam a22003974a 4500 | ||
|---|---|---|---|
| 005 | 20250914143206.0 | ||
| 008 | 040820s2005 njua b 001 0 eng | ||
| 020 |
_a0471668273 (cloth : alk. paper) _cRM360.81 |
||
| 039 | 9 |
_a200708151437 _bzainol _c200705031603 _djamil _c200704241450 _didah _c200703141326 _y03-14-2006 _zratnab |
|
| 060 |
_aQV268.5 _b.A6295 2005 |
||
| 090 | _aQV268.5.A6295 2005 9 | ||
| 090 |
_aRM411 _b.A5747 |
||
| 245 | 0 | 0 |
_aAntiviral drug discovery for emerging diseases and bioterrorism threats / _cedited by Paul F. Torrence |
| 260 |
_aHoboken, N.J. : _bWiley-Interscience, _c2005 |
||
| 300 |
_ax, 420 p. : _bill. ; _c24 cm. |
||
| 505 | 0 | _aViral bioterrorism and antiviral countermeasures / M. Bray -- Research on emerging and bioterror threats / C. Tseng -- Antiviral drug targets and strategies for emerging viral diseases and bioterrorism threats / E. de Clercq -- Perspectives for the therapy against arenavirus infections / E.B. Damonte, C.C. Garcia -- S-adenosylhomocysteine hydrolase inhibitors as a source of anti-filovirus agents / S.W. Schneller, M. Yang -- Antiviral strategies for Ebola virus / R.N. Harty and J. M. Licata -- IMPDH inhibitors : discovery of antiviral agents against emerging diseases / V. Nair -- Lethal mutagenesis : exploiting error-prone replication of riboviruses for -- Antiviral therapy / J.D. Graci, C.E. Cameron -- Structural biology of flavivral replications and opportunities for drug design / K. Murthy -- Confronting new and old antiviral threats : broad spectrum potential of prenylation inhibitors / M. Elazar, J.S. Glenn -- | |
| 505 | 0 | _aThe discovery and development of new antivirals for smallpox / E.R. Kern -- Prevention of viral infection by immunocamouflage of target tissues / L. McCoy, M.D. Scott -- Viral evasion of the interferon system : novel targets for drug discovery / L. Powell, P.F. Torrence -- The emergence of pandemic influenza : bioterrorist vs. mother nature / J. S. Oxford, A. Catchpole, R. Lambkin -- Novel approach to smallpox (variola) inhibitors / A. Rich, B. Jacobs -- Structure-based design of anti-SARS drug / R. Hilgenfeld | |
| 650 | 2 |
_aAntiviral Agents _xtherapeutic use |
|
| 650 | 2 |
_aBioterrorism _xprevention & control |
|
| 650 | 2 |
_aCommunicable Diseases, Emerging _xdrug therapy |
|
| 650 | 0 | _aAntiviral agents | |
| 650 | 0 | _aDrug development | |
| 650 | 0 | _aBioterrorism | |
| 700 | 1 | _aTorrence, Paul F. | |
| 856 | 4 | 1 |
_3Table of contents _uhttp://www.loc.gov/catdir/toc/ecip0422/2004019934.html |
| 856 | 4 | 2 |
_3Contributor biographical information _uhttp://www.loc.gov/catdir/enhancements/fy0616/2004019934-b.html |
| 856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0616/2004019934-d.html |
| 907 |
_a.b13694777 _b2021-05-28 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV268.5.A6295 2005 9 |
||
| 914 | _avtls003323556 | ||
| 990 | _azr | ||
| 991 | _aJabatan Bioperubatan | ||
| 991 | _aPusat Pengajian Biosains & Bioteknologi | ||
| 998 |
_a(2)d _at _b2006-01-03 _cm _da _feng _gnju _y0 _z.b13694777 |
||
| 999 |
_c368074 _d368074 |
||